Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
about
Targeted DNA mutagenesis for the cure of chronic viral infectionsTargeted gene disruption to cure HIVHematopoietic-stem-cell-based gene therapy for HIV diseaseHoming endonucleases: DNA scissors on a missionPredictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approachCurrent progress and challenges in HIV gene therapyI-PfoP3I: a novel nicking HNH homing endonuclease encoded in the group I intron of the DNA polymerase gene in Phormidium foveolarum phage Pf-WMP3Damaging the Integrated HIV Proviral DNA with TALENs.Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAARTAAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replicationGenome editing strategies: potential tools for eradicating HIV-1/AIDS.Homing endonucleases: from genetic anomalies to programmable genomic clippersRNA interference approaches for treatment of HIV-1 infectionTracking genome engineering outcome at individual DNA breakpointsDetection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.The clinical applications of genome editing in HIV.HIV/AIDS eradicationZinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells.Analysis of Repair Mechanisms following an Induced Double-Strand Break Uncovers Recessive Deleterious Alleles in the Candida albicans Diploid Genome.Novel fluorescent genome editing reporters for monitoring DNA repair pathway utilization at endonuclease-induced breaks.In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing EndonucleaseExperimental Approaches for Eliminating Latent HIV.Targeted gene therapies: tools, applications, optimizationCreating genetic resistance to HIV.DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells.Zinc finger nuclease: a new approach for excising HIV-1 proviral DNA from infected human T cells.Fight fire with fire: Gene therapy strategies to cure HIV.Anti-proliferative therapy for HIV cure: a compound interest approach.Disruption or Excision of Provirus as an Approach to HIV Cure.Clinical Applications of Genome Editing to HIV Cure.Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS.Genome editing technologies to fight infectious diseases.CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?
P2860
Q24620150-92B43BE9-9F0F-4FE0-A7F9-31BC23A2987AQ27023171-88CBE146-3843-474F-9563-92C4AC7FF0A8Q27023434-D87DE704-EA6A-4A92-B521-6A6D0DF8D1C9Q27023722-EE5610F3-1D1B-4A21-B6D1-81987F3252ECQ27324340-3099AAC2-DE18-40B8-8137-E5689A2A56E1Q29393523-B1A91DF3-1951-4BA9-B2E8-73DA668B30F5Q34405520-6FC100F8-A9B8-4BDA-9141-33098FDC965DQ34475249-95590DDD-14D7-4DBB-8A74-B813FAD828F9Q34647798-21EE211E-6145-4BCF-9F02-6C51A97A5288Q35168444-5932548D-012C-47C3-9170-5968647C08E2Q35612053-0D0DFD32-5E8C-4E6F-8C6F-33127DF0E687Q35621488-440F978C-F83B-42B2-86C0-BE5C1F7967E6Q35652119-BD74C423-41D6-43E5-99F1-F13AFE703458Q36152352-AB57E492-14AE-4D8A-9BC3-DAD06C4F8EC9Q36494284-2E1DCC24-694A-41AB-9544-03CE48987949Q36942032-D95E1AC6-E070-4BB0-B20D-8EF600E41A51Q37021788-4ADF7D9D-7878-42CF-9243-49CFBB3EBBD6Q37148527-B6D15206-D7FF-4783-BB91-D92AC292BAEBQ37335085-DFE9E0BF-4DC6-4FBA-906C-E37F9C15CC65Q37417038-6FF02F4B-3ECE-49CB-828A-C5FC56C270C1Q37634060-4B7F397B-78FD-41F2-ABD2-6EA09C95F8B1Q37636531-1C457172-0EBD-4E54-875D-59F46AA5B0BDQ38005211-00159DF5-9042-4A10-9411-E981E21AAAAEQ38044070-861AB292-A7B7-4250-9C93-E84D37D8E1A4Q38184158-C9441D84-15A0-41FA-9075-4139265AF774Q39166616-53E759C7-D082-45C1-9772-731B211162D0Q39168458-084DFB69-9B99-44B2-AFAE-100427D6DDE4Q39425614-A68D3A1E-E35F-499F-9B52-14DDC06EB3F9Q40150493-BA1EE348-10C5-4C12-9A2E-4D3172FEA8BAQ40448071-1DD02CA3-DA1D-4953-BD9A-C21C25760610Q40448468-E5FAF3BD-0E18-4FB1-918A-7A931F6B94A8Q40829178-D45BD6AC-3087-4F49-8D77-E4E0128F6D88Q47392998-01D30159-4CA1-4AEC-AF27-C9A613EBF52DQ52430698-37FF1160-3ED0-41F5-9932-5026F392B654
P2860
Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Successful targeting and disru ...... homing endonuclease Y2 I-AniI.
@ast
Successful targeting and disru ...... homing endonuclease Y2 I-AniI.
@en
type
label
Successful targeting and disru ...... homing endonuclease Y2 I-AniI.
@ast
Successful targeting and disru ...... homing endonuclease Y2 I-AniI.
@en
prefLabel
Successful targeting and disru ...... homing endonuclease Y2 I-AniI.
@ast
Successful targeting and disru ...... homing endonuclease Y2 I-AniI.
@en
P2093
P2860
P1433
P1476
Successful targeting and disru ...... homing endonuclease Y2 I-AniI.
@en
P2093
Andrew M Scharenberg
Byoung Y Ryu
David J Rawlings
Keith R Jerome
Lindsey Banks
Martine Aubert
P2860
P304
P356
10.1371/JOURNAL.PONE.0016825
P407
P577
2011-02-09T00:00:00Z